ZOLI, Michele
 Distribuzione geografica
Continente #
NA - Nord America 41.342
AS - Asia 18.316
EU - Europa 17.855
SA - Sud America 2.566
Continente sconosciuto - Info sul continente non disponibili 412
AF - Africa 369
OC - Oceania 49
Totale 80.909
Nazione #
US - Stati Uniti d'America 40.275
SG - Singapore 5.850
GB - Regno Unito 5.685
CN - Cina 5.025
DE - Germania 3.434
IT - Italia 3.378
HK - Hong Kong 1.951
BR - Brasile 1.945
VN - Vietnam 1.689
SE - Svezia 1.364
RU - Federazione Russa 968
BD - Bangladesh 880
FI - Finlandia 790
KR - Corea 752
TR - Turchia 716
UA - Ucraina 682
CA - Canada 545
FR - Francia 493
IN - India 302
BG - Bulgaria 267
AR - Argentina 227
ID - Indonesia 189
MX - Messico 167
NL - Olanda 143
IQ - Iraq 129
JP - Giappone 118
ZA - Sudafrica 117
EC - Ecuador 90
ES - Italia 87
CO - Colombia 81
PL - Polonia 81
IE - Irlanda 74
PK - Pakistan 74
MY - Malesia 73
AE - Emirati Arabi Uniti 71
BE - Belgio 64
IL - Israele 62
CL - Cile 61
CR - Costa Rica 60
PH - Filippine 58
VE - Venezuela 56
LT - Lituania 49
AT - Austria 47
AU - Australia 46
MA - Marocco 43
UZ - Uzbekistan 43
PY - Paraguay 42
TH - Thailandia 42
IR - Iran 40
RO - Romania 39
JM - Giamaica 37
KE - Kenya 37
JO - Giordania 35
TT - Trinidad e Tobago 34
DZ - Algeria 33
SA - Arabia Saudita 33
HN - Honduras 32
CZ - Repubblica Ceca 29
PR - Porto Rico 29
TN - Tunisia 29
UY - Uruguay 28
CH - Svizzera 27
EG - Egitto 24
AZ - Azerbaigian 23
GT - Guatemala 23
NI - Nicaragua 23
NP - Nepal 21
AL - Albania 19
DO - Repubblica Dominicana 19
EU - Europa 19
PA - Panama 19
PE - Perù 19
AN - Antille olandesi 18
ET - Etiopia 17
KZ - Kazakistan 17
LB - Libano 17
TW - Taiwan 17
OM - Oman 16
PT - Portogallo 16
RS - Serbia 16
SV - El Salvador 16
BO - Bolivia 15
GE - Georgia 14
SC - Seychelles 14
BH - Bahrain 13
DK - Danimarca 12
EE - Estonia 11
NO - Norvegia 11
BY - Bielorussia 9
GP - Guadalupe 9
HU - Ungheria 9
SN - Senegal 9
BB - Barbados 8
GR - Grecia 8
NG - Nigeria 8
CU - Cuba 7
CW - ???statistics.table.value.countryCode.CW??? 7
KG - Kirghizistan 7
LU - Lussemburgo 7
LV - Lettonia 7
Totale 80.391
Città #
Ashburn 4.830
Southend 4.246
Fairfield 3.121
Santa Clara 3.114
Singapore 2.918
Hefei 2.331
Woodbridge 2.104
Chandler 1.981
Hong Kong 1.923
Houston 1.814
San Jose 1.599
Jacksonville 1.358
Council Bluffs 1.177
Seattle 1.110
Ann Arbor 1.105
Wilmington 1.078
Dearborn 1.016
Chicago 987
Cambridge 979
Nyköping 810
Los Angeles 723
Beijing 715
Seoul 709
London 683
Sunnyvale 633
Ho Chi Minh City 551
Helsinki 541
Modena 529
The Dalles 472
Como 429
New York 422
Izmir 403
Hanoi 386
Buffalo 342
Milan 330
Princeton 311
San Diego 308
Sofia 257
Eugene 231
Columbus 220
Lauterbourg 212
São Paulo 192
Dallas 170
Moscow 163
Des Moines 158
Munich 152
Shanghai 145
Salt Lake City 144
Redwood City 129
Rome 129
Boardman 127
Toronto 121
Phoenix 118
Bologna 115
Orem 112
Jakarta 110
Falls Church 97
Tokyo 92
Atlanta 89
Brooklyn 89
North Bergen 89
Philadelphia 87
Ottawa 83
Da Nang 75
Frankfurt am Main 75
Montreal 73
Guangzhou 71
Elk Grove Village 68
Johannesburg 68
Pasadena 68
Tampa 68
Kocaeli 67
Norfolk 67
Dublin 65
Chennai 64
Haiphong 64
Kent 61
Baltimore 60
Warsaw 60
Norwalk 59
Mexico City 58
Rio de Janeiro 57
Brussels 55
San Francisco 54
Bremen 51
Vancouver 51
Naples 50
Washington 50
Baghdad 49
Tulare 49
Stockholm 47
Amsterdam 46
Denver 46
Dulles 46
Longmont 46
Miano 46
Belo Horizonte 43
Brasília 42
San José 39
Melbourne 38
Totale 53.815
Nome #
Nicotinic receptors in aging and dementia 864
Neuroscienze e libero arbitrio 723
Developmental overfeeding alters hypothalamic neuropeptide mRNA levels and response to a high-fat diet in adult mice 489
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 462
D2R–striatopallidal neurons inhibit both locomotor and drug reward processes 460
The encapsulated strain TIGR4 of Streptococcus pneumoniae is phagocytosed but is resistant to intracellular killing by mouse microglia 454
Bifunctional compounds targeting both D2 and non-α7 nACh receptors: Design, synthesis and pharmacological characterization 447
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 447
7-Chloro-5-(furan-3-yl)-3-methyl-4H-benzo[e][1,2,4]thiadiazine 1,1-Dioxide as Positive Allosteric Modulator of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor. The End of the Unsaturated-Inactive Paradigm? 442
Heterogeneity and complexity of native brain nicotinic receptors 422
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 421
Activity and circadian rhythm influence synaptic Shank3 protein levels in mice 421
Alphα6-containing nicotinic acetylcholine receptors mediate nicotine-induced structural plasticity in mouse and human iPSC-derived dopaminergic neurons 406
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 404
Brain nicotinic acetylcholine receptors: native subtypes and their relevance 399
Intercellular communication in the brain: Wiring versus volume transmission 397
Specific Dopamine Sensing Based on Short-Term Plasticity Behavior of a Whole Organic Artificial Synapse 397
Wiring and volume transmission in the central nervous system: The concept of closed and open synapses 392
Studies on neuropeptide Y-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Relationship to neuroendocrine function. 391
Siagoside selectively attenuates morphological and functional striatal impairments induced by transient forebrain ischemia in rats 389
Loss of high-affinity nicotinic receptors increases the vulnerability to excitotoxic lesion and decreases the positive effects of an enriched environment 389
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 389
A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants 387
Whole organic electronic synapses for dopamine detection 387
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 387
Neurosteroids and epileptogenesis in the pilocarpine model: evidence for a relationship between P450scc induction and length of the latent period 386
LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response 386
A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes. 385
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans 385
Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum 384
Age-related alterations in tanycytes of the mediobasal hypothalamus of the male rat 383
Morphometrical evidence for a complex organization of tyrosine hydroxylase-, enkephalin- and DARPP-32-like immunoreactive patches and their codistribution at three rostrocaudal levels in the rat neostriatum. 382
Differential effects of nicotinic antagonists perfused into the nucleus accumbens or the ventral tegmental area on cocaine-induced dopamine release in the nucleus accumbens of mice 380
Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections 379
Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice 379
Degenerazione e rigenerazione nel sistema nervoso centrale: rilevanza dei fattori trofici e della trasmissione neuronale colinergica nel trofismo del sistema nervoso centrale. 379
Effects of neurotoxic and mechanical lesions of the mesostriatal dopamine pathway on striatal polyamine levels in the rat: modulation by chronic ganglioside GM1 treatment. 378
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 377
Reduced growth hormone releasing factor (GHRF)-like immunoreactivity and GHRF gene expression in the hypothalamus of aged rats. 374
Exploiting interfacial phenomena in organic bioelectronics: Conformable devices for bidirectional communication with living systems 374
Nicotine withdrawal increases body weight, neuropeptide Y and Agouti-related protein expression in the hypothalamus and decreases uncoupling protein-3 expression in the brown adipose tissue in high-fat fed mice 371
Diet-induced changes in hypothalamic pro-opio-melanocortin mRNA in the rat hypothalamus 370
Morphometrical and microdensitometrical studies on peptide- and tyrosine hydroxylase-like immunoreactivities in the forebrain of rats prenatally exposed to methylazoxymethanol acetate. 367
"Heart-cut" bidimensional achiral-chiral liquid chromatography applied to the evaluation of stereoselective metabolism, in vivo biological activity and brain response to chiral drug candidates targeting the central nervous system 365
P.1.04 Expression of histone variants H3.3 and H2a.z in the rat brain: Physiopathological and pharmacological implications 362
Heterosynaptic GABAergic plasticity bidirectionally driven by the activity of pre- and postsynaptic NMDA receptors 360
Effects of lesions and ganglioside GM1 treatment on striatal polyamine levels and nigral DA neurons. A role of putrescine in the neurotropic activity of gangliosides. 360
Distribution and relative abundance of S100 proteins in the brain of the APP23 Alzheimer’s disease model mice 359
The emergence of the volume transmission concept 357
Cellular and synaptic alterations in the aging brain. 357
Feeding and drinking responses to neuropeptide Y injections in the paraventricular hypothalamic nucleus of aged rats 356
D1 receptor mechanisms in the median eminence and their inhibitory regulation of LHRH release. 355
Changes in nicotinic acetylcholine receptor subunit mRNAs and nicotinic binding in spontaneously hypertensive stroke prone rats 355
Ryanodine receptor-2 upregulation and nicotine-mediated plasticity. 354
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 353
A correlation analysis of the regional distribution of central enkephalin and beta-endorphin immunoreactive terminals and of opiate receptors in adult and old male rats. Evidence for the existence of two main types of communication in the central nervous system: the volume transmission and the wiring transmission. 353
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 351
Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments 351
Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain 350
A single (-)-nicotine injection causes change with a time delay in the affinity of striatal D2 receptors for antagonist, but not for agonist, nor in the D2 receptor mRNA levels in the rat substantia nigra. 350
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 350
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 350
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 350
Simultaneous measurement of adenosine, dopamine, acetylcholine and 5-hydroxytryptamine in cerebral mice microdialysis samples by LC–ESI-MS/MS 349
Spermidine/spermine N-1-acetyltransferase mRNA levels show marked and region-specific changes in the early phase after transient forebrain ischemia 348
Regional and cellular distribution of spermidine/spermine N-1-acetyltransferase (SSAT) mRNA in the rat central nervous system 347
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 345
ASPECTS OF NEURAL PLASTICITY IN THE CENTRAL NERVOUS SYSTEM .5. STUDIES ON A MODEL OF TRANSIENT FOREBRAIN ISCHEMIA IN MALE SPRAGUE-DAWLEY RATS 345
Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes 345
Short- and long-term changes in striatal neurons and astroglia after transient forebrain ischemia in rats 344
ASPECTS OF NEURAL PLASTICITY IN THE CENTRAL-NERVOUS-SYSTEM .6. STUDIES OF THE EFFECTS OF GANGLIOSIDES ON BRAIN METABOLIC LESIONS 343
Selective disarrangement of the rostral telencephalic cholinergic system in heterozygous reeler mice 343
Neuromorphic Organic Devices that Specifically Discriminate Dopamine from Its Metabolites by Nonspecific Interactions 343
Diversity of native nicotinic receptor subtypes in mammalian brain 342
In vivo study of the role of a6-containing nicotinic acetylcholine receptor in retinal function using subtype-specific RDP-MII(E11R) toxin 342
Protective effects of delapril combined with indapamide or hydrochlorothiazide in spontaneously hypertensive stroke-prone rats: a comparative dose-response analysis 341
MAPPING AND COMPUTER-ASSISTED MORPHOMETRY AND MICRODENSITOMETRY OF GLUCOCORTICOID RECEPTOR IMMUNOREACTIVE NEURONS AND GLIAL-CELLS IN THE RAT CENTRAL-NERVOUS-SYSTEM 340
Nicotine and neurodegeneration in ageing 340
Evidence for the existence of ornithine decarboxylase-immunoreactive neurons in the rat brain. 340
ASPECTS OF NEURAL PLASTICITY IN THE CENTRAL NERVOUS SYSTEM .7. THEORETICAL ASPECTS OF BRAIN COMMUNICATION AND COMPUTATION 339
Corticosterone treatment counteracts lesions induced by neonatal treatment with monosodium glutamate in the mediobasal hypothalamus of the male rat 338
Evidence for the existence of a dopamine receptor of the D-1 type in the rat median eminence. 336
Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. 336
Volume transmission in the CNS and its relevance for neuropsychopharmacology 334
Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues. 332
ASPECTS OF NEURAL PLASTICITY IN THE CENTRAL-NERVOUS-SYSTEM .1. COMPUTER-ASSISTED IMAGE-ANALYSIS METHODS 330
Structural and functional diversity of native brain neuronal nicotinic receptors 330
Effects of ganglioside GM1 treatment on striatal glucose metabolism, blood flow, and protein phosphorylation of the rat. 330
Effects of nitric oxide inhibition on the spread of biotinylated dextran and on extracellular space parameters in the neostriatum of the male rat 329
SELECTIVE REDUCTION OF GLUCOCORTICOID RECEPTOR IMMUNOREACTIVITY IN THE HIPPOCAMPAL-FORMATION AND CENTRAL AMYGDALOID NUCLEUS OF THE AGED RAT 329
An improved LC-S/MS method for the quantitation of adenosine concentration in mice brain microdialysates 329
Exposure to an enriched environment selectively increases the functional response of the pre-synaptic NMDA receptors which modulate noradrenaline release in mouse hippocampus 329
A new approach to quantitate the density and antigen contents of high densities of transmitter-identified terminals. Immunocytochemical studies on different types of tyrosine hydroxylase immunoreactive nerve terminals in nucleus caudatus putamen of the rat. 327
The receptor mosaic hypothesis of the engram: Possible relevance of Boolean network modeling 326
MicroRNA-101 Regulates Multiple Developmental Programs to Constrain Excitation in Adult Neural Networks 324
Neuron-glia cross talk in rat striatum after transient forebrain ischemia 324
Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: an emerging animal-based model of schizophrenia 323
A NEW MODEL OF FOCAL BRAIN ISCHEMIA BASED ON THE INTRACEREBRAL INJECTION OF ENDOTHELIN-1 323
Pharmacological manipulation of brain galaninergic system and sexual behavior in male mice 322
ASPECTS OF NEURAL PLASTICITY IN THE CENTRAL-NERVOUS-SYSTEM .4. CHEMICAL ANATOMICAL STUDIES ON THE AGING BRAIN 321
Totale 37.491
Categoria #
all - tutte 294.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 294.769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.573 0 0 0 0 137 227 315 296 571 370 942 715
2022/20234.947 649 629 461 427 543 724 73 474 585 45 208 129
2023/20242.759 121 190 322 262 534 270 189 322 67 61 121 300
2024/202513.151 638 115 147 815 2.098 1.595 957 682 1.073 1.292 2.130 1.609
2025/202621.738 1.794 1.154 1.958 2.110 2.585 1.656 2.203 1.225 2.377 1.942 1.434 1.300
2026/20278.064 870 1.893 1.883 2.771 647 0 0 0 0 0 0 0
Totale 80.909